以患者为中心的移动健康应用程序激励卵巢癌女性使用遗传咨询:一项初步随机对照试验
该初步随机对照试验纳入104例未接受检测的上皮性卵巢癌、原发性腹膜癌或输卵管癌女性,评估为期一周的移动应用程序(mAGIC)干预能否促进遗传咨询使用。干预组与对照组遗传咨询使用率无统计学显著差异(54.5% vs 38.6%,p=0.14),但干预组遗传性癌症知识评分更高(9.4±1.0 vs 7.1±1.5,p<0.0001),且更多报告与家人谈论遗传咨询(96% vs 77%,p=0.01)。
要点
- 干预组与对照组遗传咨询使用率无统计学显著差异(54.5% vs 38.6%,p=0.14)。
- 干预组遗传性癌症知识评分高于对照组(9.4±1.0 vs 7.1±1.5,p<0.0001),持续至少三个月。
- 干预组96%报告与家人谈论遗传咨询,对照组77%(p=0.01)。
核心结论
- mAGIC干预未增加遗传咨询的使用率,但提供了显著的次要获益,包括提高参与者对遗传性卵巢癌的知识、自我效能及报告的家庭成员沟通。
研究设计与样本
- 前瞻性、随机、对照初步试验,纳入104例有上皮性卵巢癌、原发性腹膜癌或输卵管癌病史且未接受检测的女性。
- 移动应用程序干预基于福格行为模型,包括识别障碍、开发动机因素和提供行动触发三部分,内容开发以健康信念模型为指导。
主要发现
- 遗传咨询使用率干预组54.5% vs 对照组38.6%(p=0.14),两组均较历史对照改善但组间无统计学显著差异。
- 遗传性癌症知识评分(0-10分)干预组9.4±1.0 vs 对照组7.1±1.5(p<0.0001),持续至少三个月。
- 干预组96%报告与家人谈论遗传咨询,对照组77%(p=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite current guidelines recommending women with ovarian cancer receive genetic risk evaluation by a genetic counselor, utilization has historically been low. We sought to assess the feasibility and effectiveness of a week-long mobile Application for Genetic Information on Cancer (mAGIC) intervention aimed to persuade women with ovarian cancer to pursue genetic counseling. METHODS: The mobile application intervention was based on the Fogg Behavior Model, and consisted of three parts: (1) identifying barriers, (2) developing motivators, and (3) providing triggers to action. The Health Belief Model was used to guide content development. We conducted a prospective, randomized, controlled pilot trial among 104 untested women with a history of epithelial ovarian, primary peritoneal or fallopian tube cancer with the primary objective of increasing uptake of cancer genetic counseling services. RESULTS: Utilization of cancer genetic counseling services improved in both study arms over historical controls, however there was no statistically significant difference between them (intervention: 54.5% versus control: 38.6%; p = 0.14). However, compared to controls, women randomized to the mAGIC intervention demonstrated greater knowledge of hereditary cancer (0-10 scale; 9.4 ± 1.0 vs. 7.1 ± 1.5; p < 0.0001), which persisted for at least three months. Additionally, 96% of women in the intervention group reported they had talked with their family about genetic counseling compared to 77% in the control group (p = 0.01). CONCLUSIONS: The mAGIC intervention did not result in increased uptake of genetic counseling, however it provided significant secondary benefits, including increased participants' knowledge about hereditary ovarian cancer, self-efficacy, and their reported communication with family members. ClinicalTrials.gov Identifier: NCT02877862.
引用
- Vogel RI, Niendorf K, Petzel S, et al. A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial. Gynecol Oncol. 2019. PMID: 30718125. doi:10.1016/j.ygyno.2019.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。